Overview
Fowler syndrome, also known as Fowler urethral sphincter dysfunction syndrome, is a rare condition primarily affecting young women, characterized by urinary retention due to a failure of the external urethral sphincter to relax during voiding. The condition was first described by Professor Clare Fowler and typically presents in premenopausal women, often in their 20s and 30s. The underlying mechanism involves abnormal electromyographic (EMG) activity in the striated muscle of the urethral sphincter, which demonstrates a characteristic pattern of complex repetitive discharges and decelerating bursts. This abnormal sphincter activity results in an elevated urethral closure pressure that prevents normal bladder emptying, leading to painless urinary retention with large residual volumes. The primary body system affected is the lower urinary tract, specifically the external urethral sphincter and bladder function. Patients typically present with an inability to void or incomplete bladder emptying, often with bladder volumes exceeding one liter at the time of diagnosis. The condition is frequently associated with polycystic ovaries, suggesting a possible hormonal component in its pathogenesis. Some patients may also experience associated symptoms such as constipation or other pelvic floor dysfunction. Management of Fowler syndrome centers on sacral neuromodulation (also known as sacral nerve stimulation), which has been shown to be an effective treatment for restoring voiding function in many affected women. This involves the implantation of a device that delivers electrical stimulation to the sacral nerve roots, particularly S3, which helps to modulate the abnormal sphincter activity and restore the voiding reflex. Prior to the availability of sacral neuromodulation, patients were typically managed with clean intermittent self-catheterization. Conventional treatments for urinary retention, such as alpha-blockers, are generally ineffective in this condition.
Also known as:
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for Fowler urethral sphincter dysfunction syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Fowler urethral sphincter dysfunction syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Fowler urethral sphincter dysfunction syndrome.
Community
No community posts yet. Be the first to share your experience with Fowler urethral sphincter dysfunction syndrome.
Start the conversation →Latest news about Fowler urethral sphincter dysfunction syndrome
No recent news articles for Fowler urethral sphincter dysfunction syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Fowler urethral sphincter dysfunction syndrome
What is Fowler urethral sphincter dysfunction syndrome?
Fowler syndrome, also known as Fowler urethral sphincter dysfunction syndrome, is a rare condition primarily affecting young women, characterized by urinary retention due to a failure of the external urethral sphincter to relax during voiding. The condition was first described by Professor Clare Fowler and typically presents in premenopausal women, often in their 20s and 30s. The underlying mechanism involves abnormal electromyographic (EMG) activity in the striated muscle of the urethral sphincter, which demonstrates a characteristic pattern of complex repetitive discharges and decelerating b
How is Fowler urethral sphincter dysfunction syndrome inherited?
Fowler urethral sphincter dysfunction syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Fowler urethral sphincter dysfunction syndrome typically begin?
Typical onset of Fowler urethral sphincter dysfunction syndrome is adult. Age of onset can vary across affected individuals.
Which specialists treat Fowler urethral sphincter dysfunction syndrome?
1 specialists and care centers treating Fowler urethral sphincter dysfunction syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.